- Tytuł:
-
PIN3 COST-EFFECTIVENESS ANALYSIS OF COMBINED THERAPY WITH PEGINTERFERONALFA2A (40KD) (PEGASYS®) AND RIBAVIRIN (COPEGUS®) IN PATIENTS WITH CHRONIC
C HEPATITIS (CHC)AND PERSISTENTLY NORMAL ALT LEVELS (PNALT) - Autorzy:
- Źródło:
- In Value in Health 2005 8(6):A56-A56
Czasopismo naukowe